Cargando…
Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study
BACKGROUND: Intravenous recombinant tissue plasminogen activator (r-tPA) and urokinase (UK) are both recommended for the treatment of acute ischaemic stroke (AIS) in China, but with few comparative outcome data being available. We aimed to compare the outcomes of these two thrombolytic agents for th...
Autores principales: | Wang, Xinhong, Li, Xiaoqiu, Xu, Yuming, Li, Runhui, Yang, Qingcheng, Zhao, Yong, Wang, Fengyun, Sheng, Baoying, Wang, Runqing, Chen, Shaoyuan, Wang, Lihua, Shen, Liying, Hou, Xiaowen, Cui, Yu, Wang, Duolao, Peng, Bin, Anderson, Craig S, Chen, Huisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717806/ https://www.ncbi.nlm.nih.gov/pubmed/33903179 http://dx.doi.org/10.1136/svn-2020-000640 |
Ejemplares similares
-
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022) -
Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice
por: Foerch, Christian, et al.
Publicado: (2013) -
Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19
por: Carneiro, Thiago, et al.
Publicado: (2020) -
D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke
por: Wang, Yan, et al.
Publicado: (2020) -
Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study
por: Hou, Xiaowen, et al.
Publicado: (2018)